Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nasopharyngeal Nonkeratinizing Carcinoma”

15 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 15 of 15 results

Testing effectiveness (Phase 2)Looking for participantsNCT06019130
What this trial is testing

Nivolumab in Children and Adults With Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal CarcinomaNasopharyngeal CancerNasopharyngeal Neoplasms+1 more
German Society for Pediatric Oncology and Hematology GPOH gGmbH 57
Very early researchLooking for participantsNCT05587543
What this trial is testing

Clinical Study on the EBV CAR-T /TCR-T Cells in the Treatment of Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Fudan University 24
Early research (Phase 1)WithdrawnNCT00515957
What this trial is testing

Study of LMP1- and LMP2- Specific Cytotoxic T-Lymphocytes (CTL)

Who this might be right for
NASOPHARYNGEAL CARCINOMA
Baylor College of Medicine
Early research (Phase 1)Study completedNCT00609219
What this trial is testing

T-Lymphocytes in Treating Patients With Epstein-Barr Virus-Positive Nasopharyngeal Cancer, NPC

Who this might be right for
Head and Neck Cancer
Baylor College of Medicine 25
Early research (Phase 1)Active Not RecruitingNCT02065362
What this trial is testing

TGF-beta Resistant Cytotoxic T-lymphocytes in Treatment of EBV-positive Nasopharyngeal Carcinoma / RESIST-NPC

Who this might be right for
EBV-positive Nasopharyngeal Carcinoma
Baylor College of Medicine 14
Early research (Phase 1)Study completedNCT00078546
What this trial is testing

EBV-Specific CTLs Following CD45 Antibody to Patients With Epstein-Barr Virus (EBV) + Nasopharyngeal Carcinoma (NPC)

Who this might be right for
Nasopharyngeal CancerEBV Infections
Baylor College of Medicine 12
Large-scale testing (Phase 3)UnknownNCT03656965
What this trial is testing

EBV Positive Nasopharyngeal Carcinoma Treated With Concurrent Chemo-radiotherapy With or Without Anti-Viral Drug

Who this might be right for
Drug Use for Unapproved Schedule
Kuwait Cancer Control Center 50
Very early researchUnknownNCT05654077
What this trial is testing

EBV CAR-T Cells for Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
The Affiliated Hospital of Xuzhou Medical University 24
Early research (Phase 1)Study completedNCT00516087
What this trial is testing

LMP1- and LMP2-Specific CTLs to Patients With EBV-Positive NPC (NATELLA)

Who this might be right for
Nasopharyngeal Carcinoma
Baylor College of Medicine 23
Testing effectiveness (Phase 2)Ended earlyNCT03682055
What this trial is testing

Phase 1/2a Study of VK-2019 in Patients With Epstein-Barr Virus (EBV)-Positive Nasopharyngeal Carcinoma (NPC)

Who this might be right for
Nasopharyngeal CarcinomaNasopharyngeal Cancer
Cullinan Therapeutics Inc. 14
Testing effectiveness (Phase 2)Study completedNCT00953420
What this trial is testing

Carboplatin and Docetaxel Followed by Epstein-Barr Virus Cytotoxic T Lymphocytes

Who this might be right for
Nasopharyngeal Carcinoma
Baylor College of Medicine 20
Testing effectiveness (Phase 2)UnknownNCT00690872
What this trial is testing

Gemcitabine and Carboplatin Followed By Laboratory-Treated T Lymphocytes in Treating Patients With Metastatic or Locally Recurrent Epstein-Barr Virus-Positive Nasopharyngeal Cancer

Who this might be right for
Head and Neck Cancer
National Cancer Centre, Singapore 35
Testing effectiveness (Phase 2)Study completedNCT02339558
What this trial is testing

Nivolumab in Treating Patients With Recurrent and/or Metastatic Nasopharyngeal Cancer

Who this might be right for
Nasopharyngeal Nonkeratinizing CarcinomaRecurrent Nasopharynx CarcinomaStage III Nasopharyngeal Carcinoma AJCC v7+4 more
National Cancer Institute (NCI) 45
Early research (Phase 1)Study completedNCT05864924
What this trial is testing

BRG01 in Subjects With Relapsed/Metastatic Epstein-Barr Virus (EBV)-Positive Nasopharyngeal Carcinoma

Who this might be right for
EBV-positive Nasopharyngeal Carcinoma
BioSyngen Pte Ltd 14
Large-scale testing (Phase 3)Ended earlyNCT04458909
What this trial is testing

Testing the Addition of an Anti-cancer Immune Therapy Drug (Nivolumab) to the Usual Chemotherapy Treatment (Cisplatin or Carboplatin With Gemcitabine) for Recurrent or Metastatic Nasopharyngeal Cancer

Who this might be right for
Metastatic Nasopharyngeal CarcinomaMetastatic Nasopharyngeal Keratinizing Squamous Cell CarcinomaMetastatic Nasopharyngeal Nonkeratinizing Carcinoma+8 more
National Cancer Institute (NCI) 15